Biogen Acquires Remedy Pharmaceuticals’ CIRARA™ for Large Hemispheric Stroke

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. SPY
2. PATH
3. KBH
4. USO
5. AZO
6. QQQ
7. RCL
8. ORCL
9. ONON
10. PLTR

Go back to Biogen Acquires Remedy Pharmaceuticals’ CIRARA™ for Large Hemispheric Stroke

Biogen (BIIB) PT Raised to $442 at Piper Jaffray

May 15, 2017 10:26 AM EDT

Piper Jaffray raised its price target on Biogen (NASDAQ: BIIB) to $442.00 (from $332.00) while maintaining a Overweight rating.

... More